Bank of America Corporation »

Monte Rosa Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $456k 81k 5.65
2023-09-30 $391k 82k 4.79
2023-06-30 $576k 84k 6.85
2023-03-31 $389k 50k 7.79
2022-12-31 $602k 79k 7.61
2022-06-30 $1.2M 126k 9.67
2021-12-31 $1.3M 66k 20.51